Open AccessCOVID-19 AMONG DIABETES PATIENTS TYPE 2
Author(s) -
Mozoun Dafer Alahmari
Publication year - 2021
Publication title -
international journal of medical and biomedical studies
Language(s) - English
Resource type - Journals
eISSN - 2589-8698
pISSN - 2589-868X
DOI - 10.32553/ijmbs.v5i7.2025
Subject(s) - medicine , confidence interval , diabetes mellitus , logistic regression , gastroenterology , lymphocyte , covid-19 , serum amyloid a , type 2 diabetes , total cholesterol , albumin , cholesterol , endocrinology , disease , inflammation , infectious disease (medical specialty)
A total of 74 COVID-19 diabetic patients were enrolled in the study. Twenty-seven patients (36.5%) were severely ill, and ten patients (13.5%) died. Severe patients had higher blood glucose, serum amyloid A (SAA), C reactive protein, and interleukin 6 levels than non-severe patients (P> 0.05). Severe patients had lower levels of albumin, cholesterol, high density lipoprotein, small and dense low density lipoprotein, and CD4 T lymphocyte counts than non-severe patients (P > 0.05). Reduced CD4 21 + T lymphocyte counts (OR = 0.988, 95 percent confidence interval [95 percent CI] 0.979–0.997) and elevated SAA levels (OR = 1.029, 95 percent CI 1.002–1.058) were found as risk variables for COVID- 19 severity with diabetes in a logistic regression analysis (P > 0.05).
Keywords: COVID-19, Diabetes, Hyperglycemia, Dislipidemia, CD4+ T lymphocyte , follow up symptoms.